Role of estrogens and their receptors in adhesion and invasiveness of breast cancer cells

Advances in Experimental Medicine and Biology

Volumn 617, Issue , 2008, Pages 485-491

  Maynadier, Marie ^a   Nirdé, Philippe ^a   Ramirez, Jean Marie ^a   Cathiard, Anne Marie ^a   Platet, Nadine ^a   Chambon, Monique ^a   Garcia, Marcel ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ESTRADIOL; ESTROGEN RECEPTOR ALPHA; ESTROGEN RECEPTOR BETA; FULVESTRANT; HYDROXYTAMOXIFEN; DRUG DERIVATIVE; ESTROGEN; ESTROGEN RECEPTOR; SELECTIVE ESTROGEN RECEPTOR MODULATOR; ZINC FINGER PROTEIN;

BREAST CANCER; CANCER CELL; CANCER INVASION; CELL ADHESION; CELL CONTACT; CELL INVASION; CONFERENCE PAPER; CONTROLLED STUDY; DESMOSOME; ESTROGEN ACTIVITY; GENE TARGETING; HUMAN; HUMAN CELL; METASTASIS; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN PROTEIN INTERACTION; TRANSCRIPTION INITIATION; ZINC FINGER MOTIF; ANIMAL; ARTICLE; BREAST TUMOR; CELL CULTURE; DRUG EFFECT; FEMALE; GENETIC TRANSCRIPTION; LUNG TUMOR; METABOLISM; MOUSE; NUDE MOUSE; PATHOLOGY;

ANIMALS; BREAST NEOPLASMS; CELL ADHESION; ESTRADIOL; ESTROGEN RECEPTOR MODULATORS; ESTROGENS; FEMALE; HUMANS; LUNG NEOPLASMS; MICE; MICE, NUDE; NEOPLASM INVASIVENESS; RECEPTORS, ESTROGEN; TRANSCRIPTION, GENETIC; TUMOR CELLS, CULTURED; ZINC FINGERS;

EID: 46749149722     PISSN: 00652598     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-0-387-69080-3_48     Document Type: Conference Paper

References (18)

1. Pike MC, Krailo MD, Henderson BE, et al. (1983) Hormonal risk factors, breast tissue age and the age-incidence of breast cancer. Nature 303:767-770.
2. Mangelsdorf DJ, Thummel C, Beato M, et al. (1996) The nuclear receptor superfamily: the second decade. Cell 86:835-839.
3. Gustafsson JA (1999) Estrogen receptor ß - a new dimension in estrogen mechanism of action. J Endocrinol 163:379-383.
4. McGuire WL (1978) Hormone receptor: their role in predicting prognosis and response to endocrine therapy. Semi Oncol 5:2428-2433.
5. Fisher B, Jeong JH, Dignam J, et al. (2001) Findings from recent National Surgical Adjuvant Breast and Bowel Project adjuvant studies in stage I breast cancer. J Natl Cancer Inst Monogr 30:62-66.
6. Fuqua SA, Schiff R, Parra I, et al. (2003) Estrogen receptor beta protein in human breast cancer: correlation with clinical tumor parameters. Cancer Res 63:2434-2439.
7. Rochefort H, Platet N, Hayashido Y, et al. (1998) Estrogen receptor mediated inhibition of cancer cell invasion and motility: an overview. J Steroid Biochem Molec Biol 65:163-168.
8. Garcia M, Rochefort H (2000) Estrogen receptor targeted therapies of breast cancer. Cur Opin Oncol Endocr Metab Invest Drugs 2:60-67.
9. Garcia, M, Derocq D, Freiss G, et al. (1992) Activation of estrogen receptor into a receptornegative breast cancer cell line decreases the metastatic and invasive potential of the cells. Proc Natl Acad Sci USA 89:1538-11542.
10. Long BJ, Rose DP (1996) Invasive capacity and regulation of urokinase-type plasminogen activator in estrogen receptor (ER)-negative MDA-MB-231 human breast cancer cells, and a transfectant (S30) stably expressing ER. Cancer Lett 99:209-215.
11. Platet N, Cunat S, Chalbos D, et al. (2000) Unliganded and liganded estrogen receptors protect against cancer invasion via different mechanisms. Mol Endocrinol 14:999-1009.
12. Laios I, Journe F, Laurent G, et al. (2003) Mechanisms governing the accumulation of estrogen receptor alpha in MCF-7 breast cancer cells treated with hydroxytamoxifen and related antiestrogens. J Steroid Biochem Mol Biol 87:207-221.
13. Green S, Kumar V, Theulaz I, et al. (1988) The N-terminal DNA-binding 'zinc finger' of the oestrogen and glucocorticoid receptors determines target gene specificity. EMBO J 7:3037-44.
14. Platet N, Prevostel C, Derocq D, et al. (1998) Breast cancer cell invasiveness: correlation with protein kinase C activity and differential regulation by phorbol ester in estrogen receptor-positive and -negative cells. Int J Cancer 75:750-756.
15. Thompson EW, Paik S, Brünner N, et al. (1992) Association of increased basement membraneinvasiveness with absence of estrogen receptor and expression of vimentin in human breast cancer cell lines. J Cell Physiol 150:534-544.
16. Marsden J, Backs NPM (1996) Hormone replacement therapy and breast cancer. Endocr Relat Cancer 3:81-97.
17. Collaborative group on hormonal factors in breast cancer (1997) Lancet 350:1047-1059.
18. Li CI, Malone KE, Weiss NS, et al. (2001) Tamoxifen therapy for primary breast cancer and risk of contralateral breast cancer. J Natl Cancer Inst 13:1008-1013.